Search Results - "Tompkins, D. Andrew"

Refine Results
  1. 1

    Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies by Liao, Caiyun, Zhang, Dongyu, Mungo, Chemtai, Andrew Tompkins, D, Zeidan, Amer M

    Published in Gynecologic oncology (01-10-2014)
    “…Abstract Objective To assess the association between diabetes mellitus (DM) and the incidence and disease-specific mortality of endometrial cancer (EC)…”
    Get full text
    Journal Article
  2. 2

    Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients by Dunn, Kelly E., Finan, Patrick H., Andrew Tompkins, D., Strain, Eric C.

    Published in Addictive behaviors (01-01-2018)
    “…Opioid use disorder (OUD) is a significant public health problem, and opioid maintenance treatment (OMT) on methadone or buprenorphine is a common approach…”
    Get full text
    Journal Article
  3. 3

    "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums by Meacham, Meredith C, Nobles, Alicia L, Tompkins, D Andrew, Thrul, Johannes

    Published in PloS one (08-02-2022)
    “…A growing body of research has reported on the potential opioid-sparing effects of cannabis and cannabinoids, but less is known about specific mechanisms. The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial by Umbricht, Annie, DeFulio, Anthony, Winstanley, Erin L, Tompkins, D. Andrew, Peirce, Jessica, Mintzer, Miriam Z, Strain, Eric C, Bigelow, George E

    Published in Drug and alcohol dependence (01-07-2014)
    “…Abstract Background Dual dependence on opiate and cocaine occurs in about 60% of patients admitted to methadone maintenance and negatively impacts prognosis (…”
    Get full text
    Journal Article
  6. 6

    Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon? by Tompkins, D. Andrew, Campbell, Claudia M.

    Published in Current pain and headache reports (01-04-2011)
    “…Opioids have become the unequivocal therapy of choice in treating many varieties of chronic pain. With the increased prescription of opioids, some unintended…”
    Get full text
    Journal Article
  7. 7

    Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals by Huhn, Andrew S., Strain, Eric C., Bigelow, George E., Smith, Michael T., Edwards, Robert R., Tompkins, D. Andrew

    Published in Anesthesiology (Philadelphia) (01-01-2019)
    “…WHAT WE ALREADY KNOW ABOUT THIS TOPIC WHAT THIS ARTICLE TELLS US THAT IS NEW BACKGROUND:Managing acute pain in buprenorphine-maintained individuals in…”
    Get full text
    Journal Article
  8. 8

    Substance Use in the Performing Artist with Chronic Pain by Hay, Kaitlyn R, Jardot, Jasmyne, Huhn, Andrew S, Tompkins, D Andrew

    Published in Medical problems of performing artists (01-03-2022)
    “…OBJECTIVES: To evaluate how performing artists (PAs) with chronic pain may differ on measures of substance use compared to non-PA controls. METHODS: 157…”
    Get full text
    Journal Article
  9. 9

    Providing chronic pain management in the “Fifth Vital Sign” Era: Historical and treatment perspectives on a modern-day medical dilemma by Tompkins, D. Andrew, Hobelmann, J. Greg, Compton, Peggy

    Published in Drug and alcohol dependence (01-04-2017)
    “…Highlights • Prior to the 1980s, chronic pain management was mostly multidisciplinary, and providers used opioids sparingly. • “Pain, The Fifth Vital Sign”…”
    Get full text
    Journal Article
  10. 10

    Extended‐release injectable naltrexone for opioid use disorder: a systematic review by Jarvis, Brantley P., Holtyn, August F., Subramaniam, Shrinidhi, Tompkins, D. Andrew, Oga, Emmanuel A., Bigelow, George E., Silverman, Kenneth

    Published in Addiction (Abingdon, England) (01-07-2018)
    “…Aims To review systematically the published literature on extended‐release naltrexone (XR‐NTX, Vivitrol®), marketed as a once‐per‐month injection product to…”
    Get full text
    Journal Article
  11. 11

    A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder by Huhn, Andrew S., Strain, Eric C., Tompkins, D. Andrew, Dunn, Kelly E.

    Published in Drug and alcohol dependence (01-12-2018)
    “…•There was a recent surge in older adults seeking treatment for opioid use disorder.•Older adults seeking treatment for heroin use increased 110% between…”
    Get full text
    Journal Article
  12. 12

    Recruitment Techniques for Alcohol Pharmacotherapy Clinical Trials: A Cost-benefit Analysis by Tompkins, D Andrew, Sides, Jessica A, Harrison, Joseph A, Strain, Eric C

    Published in Addictive disorders & their treatment (01-12-2015)
    “…OBJECTIVES:Alcohol-use disorders (AUDs) represent a large public health burden with relatively few efficacious pharmacotherapies. Randomized controlled trials…”
    Get full text
    Journal Article
  13. 13

    National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status by Pro, George, Tompkins, D. Andrew, Azari, Soraya, Zaller, Nickolas

    Published in Drug and alcohol dependence (01-11-2021)
    “…The recent surge in hepatitis C virus (HCV) prevalence is primarily due to increased injection drug use. Opioid treatment programs (OTPs) are a major source of…”
    Get full text
    Journal Article
  14. 14

    The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use by Huhn, Andrew S., Tompkins, D. Andrew, Dunn, Kelly E.

    Published in Drug and alcohol dependence (01-11-2017)
    “…•Several factors shape individual preference for treatment of opioid use disorder.•Access to treatment is predictive of initial treatment attempt in opioid…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial by Dunn, Kelly E, Tompkins, D Andrew, Bigelow, George E, Strain, Eric C

    Published in JAMA psychiatry (Chicago, Ill.) (01-09-2017)
    “…Opioid use disorder (OUD) is a significant public health problem. Supervised withdrawal (ie, detoxification) from opioids using clonidine or buprenorphine…”
    Get more information
    Journal Article
  17. 17

    Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal by Huhn, Andrew S, Tompkins, D Andrew, Campbell, Claudia M, Dunn, Kelly E

    Published in Pain medicine (Malden, Mass.) (01-10-2019)
    “…Objective Individuals with chronic pain who misuse prescription opioids are at high risk for developing opioid use disorder and/or succumbing to opioid…”
    Get full text
    Journal Article
  18. 18

    Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients by Dunn, Kelly E, Finan, Patrick H, Tompkins, D. Andrew, Fingerhood, Michael, Strain, Eric C

    Published in Drug and alcohol dependence (01-12-2015)
    “…Highlights • Many OMT patients report chronic pain that is of significant severity and interference in their life. • Most OMT patients with concurrent chronic…”
    Get full text
    Journal Article
  19. 19

    Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder by Byne, William, Bradley, Susan J., Coleman, Eli, Eyler, A. Evan, Green, Richard, Menvielle, Edgardo J., Meyer-Bahlburg, Heino F. L., Pleak, Richard R., Tompkins, D. Andrew

    Published in Archives of sexual behavior (01-08-2012)
    “…Both the diagnosis and treatment of Gender Identity Disorder (GID) are controversial. Although linked, they are separate issues and the DSM does not evaluate…”
    Get full text
    Journal Article
  20. 20